Impaired control over gaming scale (ICOGS): Development, confirmatory factor validation, and psychometric evaluation.
Addiction
Gaming disorder
Impaired control
Psychometrics
Scale development
Journal
Addictive behaviors reports
ISSN: 2352-8532
Titre abrégé: Addict Behav Rep
Pays: Netherlands
ID NLM: 101656077
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
10
10
2022
revised:
20
03
2023
accepted:
31
03
2023
medline:
19
4
2023
entrez:
18
4
2023
pubmed:
19
4
2023
Statut:
epublish
Résumé
The concept of impaired control is central to addictive disorders, including gaming disorder in the DSM-5 and ICD-11. Impaired control refers to the recurrent inability to resist impulses to engage in certain activities or behaviours and the failure to limit or stop this engagement. Although numerous screening tools for gaming disorder symptoms have been developed, these instruments have limited capacity for measuring the nature and extent of impaired control. To address this limitation, the present study reports on the creation of the Impaired Control Over Gaming Scale (ICOGS), an 8-item screening tool to assess gaming-related impaired control. A total of 513 gamers, including 125 gamers (24.3%) who met the DSM-5 criteria for gaming disorder, were recruited from The ICOGS demonstrated promising psychometric properties. Exploratory and confirmatory factor analysis using two samples provided robust support for a 2-factor model and high internal consistency of the scale. ICOGS scores were significantly and positively associated with gaming disorder symptoms, gaming-related harms, gaming frequency, psychological distress, and neuroticism. Using receiver operating characteristic analysis, the ICOGS differentiated between non-problem gamers and those who met the criteria for GD. Overall, the ICOGS appears to be a valid and reliable scale for use in studies of problem gaming, and may be useful for assessing outcomes of GD interventions that employ self-regulation and stopping techniques to reduce or eliminate problem gaming behavior.
Sections du résumé
Background and aims
UNASSIGNED
The concept of impaired control is central to addictive disorders, including gaming disorder in the DSM-5 and ICD-11. Impaired control refers to the recurrent inability to resist impulses to engage in certain activities or behaviours and the failure to limit or stop this engagement. Although numerous screening tools for gaming disorder symptoms have been developed, these instruments have limited capacity for measuring the nature and extent of impaired control. To address this limitation, the present study reports on the creation of the Impaired Control Over Gaming Scale (ICOGS), an 8-item screening tool to assess gaming-related impaired control.
Methods
UNASSIGNED
A total of 513 gamers, including 125 gamers (24.3%) who met the DSM-5 criteria for gaming disorder, were recruited from
Results
UNASSIGNED
The ICOGS demonstrated promising psychometric properties. Exploratory and confirmatory factor analysis using two samples provided robust support for a 2-factor model and high internal consistency of the scale. ICOGS scores were significantly and positively associated with gaming disorder symptoms, gaming-related harms, gaming frequency, psychological distress, and neuroticism. Using receiver operating characteristic analysis, the ICOGS differentiated between non-problem gamers and those who met the criteria for GD.
Discussion and conclusions
UNASSIGNED
Overall, the ICOGS appears to be a valid and reliable scale for use in studies of problem gaming, and may be useful for assessing outcomes of GD interventions that employ self-regulation and stopping techniques to reduce or eliminate problem gaming behavior.
Identifiants
pubmed: 37069857
doi: 10.1016/j.abrep.2023.100489
pii: S2352-8532(23)00011-1
pmc: PMC10105481
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100489Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Aust N Z J Psychiatry. 2021 Jun;55(6):553-568
pubmed: 33028074
Alcohol Clin Exp Res. 2006 Feb;30(2):265-71
pubmed: 16441275
Addiction. 2022 Jul;117(7):2119-2121
pubmed: 34882889
Addiction. 2015 May;110(5):842-51
pubmed: 25598040
Alcohol Clin Exp Res. 2014 Feb;38(2):301-8
pubmed: 24117468
Addict Behav. 2021 Nov;122:107021
pubmed: 34171583
Addiction. 1994 Feb;89(2):167-74
pubmed: 8173482
Nature. 2019 Sep;573(7774):346
pubmed: 31530926
Addiction. 2021 Sep;116(9):2463-2475
pubmed: 33449441
J Behav Addict. 2017 Sep 1;6(3):271-279
pubmed: 28816494
J Behav Addict. 2015 Dec;4(4):215-20
pubmed: 26690615
Addiction. 1998 May;93(5):761-71
pubmed: 9692275
J Behav Addict. 2020 Apr 01;9(1):1-13
pubmed: 32359228
Psychol Addict Behav. 2020 May;34(3):484-496
pubmed: 31971427
Behav Res Methods. 2016 Sep;48(3):936-49
pubmed: 26174714
Curr Opin Behav Sci. 2022 Jun 11;46:101158
pubmed: 35746944
Int J Ment Health Addict. 2022;20(5):2906-2921
pubmed: 34121958
Br J Addict. 1990 Nov;85(11):1403-8
pubmed: 2285834
Addict Behav. 2017 Feb;65:125-130
pubmed: 27816037
Addict Behav. 1990;15(5):487-90
pubmed: 2248123
Aust N Z J Psychiatry. 2018 Jul;52(7):615-617
pubmed: 29701485
Eur Neuropsychopharmacol. 2018 Nov;28(11):1232-1246
pubmed: 30509450
J Stud Alcohol. 1993 Nov;54(6):700-9
pubmed: 8271806
Neurosci Biobehav Rev. 2019 Sep;104:1-10
pubmed: 31247240
J Gambl Stud. 1990 Jun;6(2):165-82
pubmed: 24242857
Br J Addict. 1989 Dec;84(12):1527-37
pubmed: 2611437
Addiction. 2014 Sep;109(9):1399-406
pubmed: 24456155
J Appl Meas. 2004;5(4):398-418
pubmed: 15496747
Addiction. 2003 Jan;98(1):53-60
pubmed: 12492755
Nature. 2015 Jun 25;522(7557):S62
pubmed: 26107100
Clin Psychol Rev. 2020 Apr;77:101831
pubmed: 32143109
J Behav Addict. 2021 Apr 13;10(2):208-222
pubmed: 33852420
Curr Opin Psychol. 2020 Dec;36:49-54
pubmed: 32480020
Addict Behav. 2014 Dec;39(12):1827-30
pubmed: 25128635
J Clin Med. 2019 Jan 15;8(1):
pubmed: 30650522
Curr Opin Neurobiol. 2015 Feb;30:66-72
pubmed: 25262209
Dev Med Child Neurol. 2018 Jul;60(7):645-659
pubmed: 29633243
Alcohol Clin Exp Res. 2010 Aug;34(8):1346-52
pubmed: 20491732
Psychiatry Clin Neurosci. 2017 Jul;71(7):459-466
pubmed: 27278653
Dialogues Clin Neurosci. 2020 Jun;22(2):113-126
pubmed: 32699511
Addict Behav. 2021 Jul;118:106885
pubmed: 33684870
J Clin Med. 2022 Aug 04;11(15):
pubmed: 35956181
Addict Behav. 2021 Jan;112:106633
pubmed: 32949836
Aust N Z J Psychiatry. 2022 Apr;56(4):332-346
pubmed: 34250835
Exp Clin Psychopharmacol. 2012 Apr;20(2):92-106
pubmed: 22182417
World Psychiatry. 2021 Jun;20(2):198-199
pubmed: 34002495
J Behav Addict. 2020 Jun 30;:
pubmed: 32634114
Psychol Rep. 2005 Jun;96(3 Pt 1):644-6
pubmed: 16050617
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
Psychopharmacology (Berl). 2018 May;235(5):1487-1496
pubmed: 29497782